ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Scalable Purification of Iron Oxide Nanoparticles for Organ Cryopreservation and Transplantation.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Mathematical Modeling of Liver Metabolic Activity Under Ex Vivo Conditions upon Exposure to Magnetic Nanoparticles.Biomedicines · 2026Article
- In vivo toxicity assessment of silica-coated iron oxide nanoparticles for nanowarming in organ cryopreservation.Journal of nanobiotechnology · 2026Article
- Thermodynamic Principles of Emerging Cryopreservation Technologies.Methods in molecular biology (Clifton, N.J.) · 2026Review
- Nanomedicine in Organ Transplantation: From Graft Preservation and Repair to Immunomodulation and Monitoring.Theranostics · 2026Review
- Scalable Purification of Iron Oxide Nanoparticles for Organ Cryopreservation and Transplantation.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Our group recently reported the successful transplant of cryopreserved rat kidneys that independently supported the life of recipient rats, marking a key step toward human-scale organ cryopreservation. In vitrification, organs are cooled to cryogenic temperatures and transformed into a glassy state, allowing indefinite storage. However, rewarming without ice formation or thermal stress-induced cracking remains a challenge. To overcome this, a technique called "nanowarming," is pioneered in which iron oxide nanoparticles (IONPs) are perfused into the organ's vasculature in combination with cryoprotective agents (CPAs). When rewarmed using a radiofrequency coil, the nanoparticles generate heat, enabling rapid and uniform warming. This method is scalable to large volumes because RF frequencies penetrate with minimal attenuation. While nanowarming is demonstrated with rat organs, clinical-scale organs will require large quantities of IONPs that must remain stable in CPAs and provide effective heating. To scale up IONP purification, tangential flow filtration (TFF) is used, which achieved the purification of 0.72 g IONPs in 2.5 h. This method reduces IONP loss and residual content in the organ, ensuring effective heating while maintaining stability. Finally, the method by successfully transplanting cryopreserved and nanowarmed rat kidneys is validated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.